1/18/2018
1
The Ascent of Spitz Nevi
Timothy McCalmont, MDUniversity of California, San Francisco
The Ascent of Spitz Nevi
Timothy McCalmont, MDUniversity of California, San Francisco
Our goals for this session
• A brief history of Spitz nevi
• A brief look into the recent events important to those of us who love Spitz nevi
• A massive review of Spitz variants
• A brief review of what is NOT a Spitz
1/18/2018
2
1. History
1/18/2018
3
1/18/2018
4
2. Recent events
Normal
Malignancy(fully transformed)
Mutation 1
Tumors arise from accumulated alterations in the genome
Mutation 2
Mutation 3
1/18/2018
5
Nevus
Melanoma
Phenotype of melanocytic nevi varies dependent on the oncogenic change
BRAF Threonine kinaseNRAS Small GTPaseGNAQ Large GTPaseGNA11 Large GTPaseHRAS Small GTPaseALK Receptor tyrosine kinaseROS1 Receptor tyrosine kinaseRET Receptor tyrosine kinaseMET Receptor tyrosine kinaseNTRK1 Receptor tyrosine kinaseNTRK3 Receptor tyrosine kinasePRKCA Threonine kinaseBRAF Threonine kinase
Point
mutations
Rearrangements
Acquired nevi
Congenital nevi
Blue nevi
Spitz nevi
Partially-transformed tumors
• With genomic loss:
• With genomic gain:
• With gene fusion/translocation:
Partially-transformed tumors
• With genomic loss:
• example: BAPoma (BAP1 loss)
• With genomic gain:
• With gene fusion/translocation:
1/18/2018
6
Partially-transformed tumors
• With genomic loss:
• example: BAPoma (BAP1 loss)
• With genomic gain:
• example: HRAS-mutant Spitz
• With gene fusion/translocation:
Partially-transformed tumors
• With genomic loss:
• example: BAPoma (BAP1 loss)
• With genomic gain:
• example: HRAS-mutant Spitz
• With gene fusion/translocation:
• example: ALKoma
ALKoma (Spitz tumor with ALK gene fusion)
1/18/2018
7
1/18/2018
8
ALK
p16
1/18/2018
9
ALKoma
• A partially transformed Spitz
• A potential setup for additional transformation
• Promiscuous; multiple fusion partners
BAPoma (Wiesner nevus; epithelioid nevus/tumor with
BAP-1 genomic loss)
1/18/2018
10
1/18/2018
11
BAP1
p16
BAPoma
• A Spitz (or at least Spitz-like because of cytomegaly) with a successful first hit with tumor suppressor loss
• Overlap with a historical spectrum that has safely been called combined Spitz nevus
1/18/2018
12
HRAS-mutated Spitz
1/18/2018
13
1/18/2018
14
HRAS-mutated Spitz nevus
1/18/2018
15
11p Spitz (HRAS-mutated)
• Large with marked desmoplasia
• Horizontal orientation, often
• Infiltrative, often
• Mitotic figures, often
• Young adults rather than young children, often
HRAS-mutated Spitz nevus
• A Spitz tumor driving down a molecular dead end
• Defined within a historical spectrum that has safely been called Spitz nevus
3. Variants galore
1/18/2018
16
Spitz subsets for today
• Standard or mainstream
• Elegant, with refined features
• Oddballs
• Tough diagnostic situations
• Contrived ones, to make a point
3a. Standard Spitz variants
• Conventional Spitz nevus
• Reed nevus (pigmented spindle cell nevus)
• Polypoid Spitz nevus
• Combined Spitz nevus
• Multiple Spitz nevi
• Agminated Spitz nevi
Conventional Spitz
1/18/2018
17
PSCN
1/18/2018
18
Fascicular PSCN
1/18/2018
19
1/18/2018
20
Polypoid Spitz nevus
1/18/2018
21
p16
1/18/2018
22
Combined Spitz
• Conventional and Spitz
• Conventional and PSCN
• Conventional and desmo Spitz
• Blue and Spitz
• Et cetera
1/18/2018
23
Multiple Spitz
1/18/2018
24
1/18/2018
25
Agminated Spitz
1/18/2018
26
1/18/2018
27
3b. Elegant Spitz subtypes
• Desmoplastic Spitz
• Hyalinized Spitz
• Angiomatoid Spitz
• Myxoid Spitz
• Perineuriomatous Spitz
• Syringofibroadenomatous Spitz
• Superficial spreading Spitz
1/18/2018
28
Desmoplastic Spitz
1/18/2018
29
1/18/2018
30
p16
p16
Hyalinized Spitz
• Probably best thought of as a subset of desmoplastic Spitz
• The degree of hyalinization varies and is occasionally extreme
1/18/2018
31
1/18/2018
32
Angiomatoid Spitz
• A subtype of desmoplastic Spitz
• All angiomatoid Spitz nevi are desmoplastic, but not all desmoplastic Spitz nevi are angiomatoid
1/18/2018
33
1/18/2018
34
Myxoid Spitz
1/18/2018
35
1/18/2018
36
Perineuriomatous Spitz
1/18/2018
37
1/18/2018
38
p16
EMA
SyringofibroadenomatousSpitz
1/18/2018
39
1/18/2018
40
1/18/2018
41
Syringeal Spitz
• In a recent analysis of 7 examples, 4/7 were induced by ROS1 gene fusion
Superficial spreading Spitz(SSSN)
1/18/2018
42
1/18/2018
43
(superficial spread)
1/18/2018
44
SSSN
• N = 41; M:F = 12:29
• Mean age 35.7 years (3-80)
• Leg: 68%
• Lateral spread: 2.1 +/- 0.8 mm
• Pagetoid: 85%; marked: 32%
• Desmoplasia: 36%
SSSN
• A minimally transformed or non-transformed Spitz
• Falls within a spectrum that has safely been called Spitz nevus
1/18/2018
45
3c. Oddball Spitz subtypes
• Spitz with edema
• Spitz with rosettes
• Palisaded Spitz/Reed nevus
• Spitz with oncocytic metaplasia
• Spitzerson nevus
Edematous Spitz
1/18/2018
46
1/18/2018
47
p16
p16
1/18/2018
48
p16
1/18/2018
49
Spitz with rosettes
1/18/2018
50
Spitz/Reed w/ palisading
1/18/2018
51
1/18/2018
52
1/18/2018
53
Oncocytic Spitz
1/18/2018
54
1/18/2018
55
Mitochondrial Ag
Mitochondrial Ag
1/18/2018
56
Spitzerson nevus (Spitz with Meyerson-like inflammation)
1/18/2018
57
p16
1/18/2018
58
Spitzerson nevus
• A non-transformed or minimally transformed Spitz
• Strong overlap with a spectrum safely called Spitz or PSCN
3d. Practical Spitz subtypes reflecting unusual or tough diagnostic situations• Pagetoid Spitz
• Special site Spitz
• Spitz with consumption
• Bottom heavy Spitz
• Spitz with meganests
• Spitz with adnexal extension
• Spitz with intralymphatic extension
• Mitotically-active Spitz
Pagetoid Spitz
1/18/2018
59
1/18/2018
60
Spitz of a ‘special site’
• Flexural Spitz nevus
• Spitz nevus of the breast
• Genital Spitz nevus
• Acral Spitz nevus
1/18/2018
61
1/18/2018
62
Acral Spitz
1/18/2018
63
1/18/2018
64
Spitz w/ consumption
1/18/2018
65
1/18/2018
66
p16
1/18/2018
67
p16
NTRK1
1/18/2018
68
1/18/2018
69
(FISH neg)
Spitz w/ meganests
1/18/2018
70
1/18/2018
71
Spitz w/ adnexal extension
1/18/2018
72
Melan-A
1/18/2018
73
1/18/2018
74
1/18/2018
75
Spitz w/ intralymphatic
1/18/2018
76
1/18/2018
77
Mitotically-active Spitz
1/18/2018
78
(NTRK3 fusion)
1/18/2018
79
Subtypes I completely made up to make a point • Spitz kneevus
• Spitz elbovis
• Spastic (hybrid) nevus
• Spitz with Kaminoettes
• Spitz with megamelanophages
Spitz kneevus
1/18/2018
80
1/18/2018
81
p16
1/18/2018
82
p16
1/18/2018
83
Spitz elbovis
1/18/2018
84
SOX-10
SOX-10
1/18/2018
85
SOX-10
Spastic nevus
Spastic nevus
• Spitzoid dysplastic nevus
• Dysplastic Spitz nevus
• Spitzoid Clark nevus
• Spark nevus
• Et cetera
1/18/2018
86
1/18/2018
87
1/18/2018
88
p16
Hybrid Spitz
1/18/2018
89
1/18/2018
90
Spitz w/ Kaminoettes
• (Tiny Kamino bodies)
• The guidelines of pink globules:
• Make sure it’s really a Kamino
• Kaminos favor the dx of Spitz
• Kaminos are rare in melanoma
• Large Kaminos = greatest impact
• Small Kaminos great if numerous
1/18/2018
91
1/18/2018
92
1/18/2018
93
Spitz with megamelanophages
1/18/2018
94
4. Even though the spectrum is broad, much is NOT a Spitz
Melanoma w/ meganests
1/18/2018
95
1/18/2018
96
PSCN-like MISPSCN-like melanoma
1/18/2018
97
1/18/2018
98
Melanomaw/ large pagetoid cells
1/18/2018
99
p16
1/18/2018
100
Conclusions
• History has oversimplified the categorization of melanocytic tumors. It’s broader that melanoma and nevus or melanoma and Spitz.
Conclusions
• There are categories that current nosology has not conceived of, including melanoma ex Spitz, low-grade melanoma, and partially-transformed but benign.
Conclusions
• In our existing paradigm, ancillary analysis provides additional insight into controversial tumors.
1/18/2018
101
Conclusions
• Morphologic analysis may be misleading, especially if imprecisely applied. In the context of melanocytic tumors, we may lump unrelated entities.
1/18/2018
102
Last thought
• While morphology earns us a living, morphologic arguments and morphologic categories may be deceptive and limiting
• That whale might be a hippo, or that hippo might be a whale